DK272389A - Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved - Google Patents

Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved Download PDF

Info

Publication number
DK272389A
DK272389A DK272389A DK272389A DK272389A DK 272389 A DK272389 A DK 272389A DK 272389 A DK272389 A DK 272389A DK 272389 A DK272389 A DK 272389A DK 272389 A DK272389 A DK 272389A
Authority
DK
Denmark
Prior art keywords
preparations
hydroxysoic
alcoholism
gamma
preparation
Prior art date
Application number
DK272389A
Other languages
English (en)
Other versions
DK272389D0 (da
DK174017B1 (da
Inventor
Gian Luigi Gessa
Fabio Fadda
Chiara Mormile Di Campochiaro
Original Assignee
Farmaceutico C T Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutico C T Lab filed Critical Farmaceutico C T Lab
Publication of DK272389D0 publication Critical patent/DK272389D0/da
Publication of DK272389A publication Critical patent/DK272389A/da
Application granted granted Critical
Publication of DK174017B1 publication Critical patent/DK174017B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198902723A 1988-06-03 1989-06-02 Anvendelse af gamma-hydroxysmørsyresalte til fremstilling af farmaceutiske præparater til behandling af alkoholisme DK174017B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20859/88A IT1217783B (it) 1988-06-03 1988-06-03 Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
IT2085988 1988-06-03

Publications (3)

Publication Number Publication Date
DK272389D0 DK272389D0 (da) 1989-06-02
DK272389A true DK272389A (da) 1989-12-04
DK174017B1 DK174017B1 (da) 2002-04-15

Family

ID=11173141

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902723A DK174017B1 (da) 1988-06-03 1989-06-02 Anvendelse af gamma-hydroxysmørsyresalte til fremstilling af farmaceutiske præparater til behandling af alkoholisme

Country Status (16)

Country Link
US (1) US4983632A (da)
EP (1) EP0344704B1 (da)
AR (1) AR241512A1 (da)
AT (1) ATE126433T1 (da)
AU (1) AU633002B2 (da)
CA (1) CA1330423C (da)
DE (1) DE68923819T2 (da)
DK (1) DK174017B1 (da)
ES (1) ES2075011T3 (da)
FI (1) FI892718L (da)
GR (1) GR3018009T3 (da)
IT (1) IT1217783B (da)
NO (1) NO892270L (da)
NZ (1) NZ229399A (da)
PT (1) PT90732B (da)
ZA (1) ZA894128B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153219A (en) * 1991-04-22 1992-10-06 Morris D. Faiman Thiocarbamate sulfoxide composition for deterring ethanol ingestion
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism
IT1261432B (it) * 1993-03-26 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l- carnitina gammaidrossibutirrato per il trattamento dell'alcolismo.
IT1261485B (it) * 1993-06-24 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo
EP1316309A1 (en) * 1998-12-23 2003-06-04 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
DK1140061T3 (da) 1998-12-23 2003-08-25 Orphan Medical Inc Mikrobiologisk sunde og stabile opløsninger af gamma-hydroxybutyratsalt til behandling af narcolepsi
ES2525553T3 (es) 1999-03-25 2014-12-26 Metabolix, Inc. Dispositivos y aplicaciones médicas de polímeros polihidroxialcanoato
US6623730B1 (en) 1999-09-14 2003-09-23 Tepha, Inc. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
ITMI20020754A1 (it) * 2002-04-09 2003-10-09 Aboca S P A Composizioni effervescenti contenenti succhi di frutta essicati
RU2210360C1 (ru) * 2002-09-19 2003-08-20 Общество С Ограниченной Ответственностью "Консорциум-Пик" Психотропное средство
EP2860292B1 (en) 2003-05-08 2020-07-22 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
ES2362217T3 (es) 2004-08-03 2011-06-29 Tepha, Inc. Suturas de polihidroxialcanoato no rizadas.
US7838556B2 (en) * 2006-02-21 2010-11-23 University Of Maryland, Baltimore Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
MX391660B (es) 2010-03-24 2025-03-21 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
CN102946869B (zh) * 2010-05-04 2016-08-03 爵士制药有限公司 γ-羟基丁酸的速释制剂及剂型
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
WO2016025329A1 (en) 2014-08-15 2016-02-18 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
EP3230500B1 (en) 2014-12-11 2025-06-18 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
CN113473980A (zh) 2019-03-01 2021-10-01 弗拉梅尔爱尔兰有限公司 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
US12582622B2 (en) 2020-10-08 2026-03-24 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
WO2024163966A1 (en) 2023-02-03 2024-08-08 Tris Pharma, Inc. Low sodium oxybate once nightly composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044801B1 (de) * 1980-07-17 1984-02-15 Josef Dr. Klosa Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel

Also Published As

Publication number Publication date
CA1330423C (en) 1994-06-28
NO892270L (no) 1989-12-04
FI892718A7 (fi) 1989-12-04
IT1217783B (it) 1990-03-30
IT8820859A0 (it) 1988-06-03
US4983632A (en) 1991-01-08
ES2075011T3 (es) 1995-10-01
AR241512A1 (es) 1992-08-31
PT90732B (pt) 1994-10-31
AU633002B2 (en) 1993-01-21
PT90732A (pt) 1989-12-29
DK272389D0 (da) 1989-06-02
DE68923819D1 (de) 1995-09-21
EP0344704A1 (en) 1989-12-06
DE68923819T2 (de) 1996-01-18
EP0344704B1 (en) 1995-08-16
NZ229399A (en) 1997-02-24
GR3018009T3 (en) 1996-02-29
FI892718A0 (fi) 1989-06-02
FI892718L (fi) 1989-12-04
ZA894128B (en) 1990-03-28
DK174017B1 (da) 2002-04-15
ATE126433T1 (de) 1995-09-15
NO892270D0 (no) 1989-06-02
AU3590489A (en) 1989-12-07

Similar Documents

Publication Publication Date Title
DK272389A (da) Anvendelse af gamma-hydroxysmoersyresalte til fremstilling af farmaceutiske praeparater til behandling af alkoholisme og praeparater opnaaet herved
DK170187D0 (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK99086A (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
DK195587D0 (da) Phenylpiperazinderivater og deres anvendelse til fremstilling af antiarrytmi-laegemidler
DK314789A (da) Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK279890A (da) Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer
DK433786D0 (da) Farmaceutiske praeparater og medicinske anvendelser af dioxopiperidinderivater
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK48886A (da) Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK522788A (da) Amidinoderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK128485D0 (da) Farmaceutisk praeparat indeholdende tetracyclin- eller doxycyclinsalte og en fremgangsmaade til fremstilling af et saadant praeparat
DK449188A (da) 2'-deoxy-5-fluoruridinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK500589A (da) Farmaceutisk praeparat til behandling af lungeobstruktioner
DK369088D0 (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK446388A (da) Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK630089D0 (da) Anvendelse af aryloxyalkanoler og estere deraf til fremstilling af farmaceutika til behandling af retrovirusinfektioner
DK159434C (da) Quinoxalinforbindelser, fremgangsmaade til deres fremstilling, en anvendelse af forbindelserne og farmaceutiske praeparater hvori forbindelserne indgaar
DK151964C (da) Beta-carbolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling af samme samt farmaceutisk praeparat
DK489186D0 (da) Fremgangsmaade til fremstilling af amidinourinstoffer og farmaceutisk praeparat
DK159685C (da) Imidazothienopyrimidiner, farmaceutiske praeparater indeholdende disse, en anvendelse af forbindelserne og fremgangsmaade til deres fremstilling
DK684487A (da) Farmaceutisk praeparat og anvendelse af enkephalinase til fremstilling af et laegemiddel

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired